The BIOS Podcast by Alix Ventures features experts and thought leaders in healthcare & life sciences. We bring you cutting-edge insights from executives, investors, founders, scientists, academics, and more. BIOS is a community of early stage healthcare and life sciences founders and investors. It is anchored by Alix Ventures, a San Francisco-based venture fund that invests in early stage healthcare and life sciences companies.
Jim Collins is a Core Faculty member at the Wyss Institute. He is also the Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science at MIT. He is affiliated with the Broad Institute. His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. Professor Collins’ patented technologies have been licensed by over 25 biotech, pharma and medical devices companies, and he has helped to launch a number of companies, including Senti Bio, Sample6 Technologies, Sherlock, Synlogic, and EnBiotix. He has received numerous awards and honors, including a Rhodes Scholarship, a MacArthur “Genius” Award, an NIH Director’s Pioneer Award, a Sanofi-Institut Pasteur Award, as well as several teaching awards. Professor Collins is an elected member of the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the American Academy of Arts & Sciences, and a charter fellow of the National Academy of Inventors.